Onderneming Enanta Pharmaceuticals, Inc.
Aandelen
ENTA
US29251M1062
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
12,37 USD | -0,88% | -7,13% | +31,46% |
09/02 | ENANTA PHARMACEUTICALS, INC. : Oppenheimer is neutraal gestemd over het aandeel | ZM |
07/02 | Transcript : Enanta Pharmaceuticals, Inc., Q1 2024 Earnings Call, Feb 07, 2024 |
Vakgebied
Aantal werknemers: 145
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Small Molecule Drugs
100,0
%
| 86 | 100,0 % | 79 | 100,0 % | -8,07% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 86 | 100,0 % | 79 | 100,0 % | -8,07% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jay Luly
CEO | Chief Executive Officer | 67 | 01-07-03 |
Paul Mellett
DFI | Director of Finance/CFO | 68 | 01-09-03 |
Chief Tech/Sci/R&D Officer | 50 | 08-08-22 | |
Yat Sun Or
CTO | Chief Tech/Sci/R&D Officer | 72 | 01-11-99 |
Jennifer Viera
IRC | Investor Relations Contact | - | 01-01-23 |
Brendan Luu
PRN | Corporate Officer/Principal | 49 | 26-01-21 |
Tara Kieffer
PRN | Corporate Officer/Principal | 46 | 08-12-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mark Foletta
BRD | Director/Board Member | 63 | 29-06-20 |
Lesley Russell
BRD | Director/Board Member | 63 | 18-11-16 |
Bruce Carter
CHM | Chairman | 80 | 25-11-13 |
Jay Luly
CEO | Chief Executive Officer | 67 | 01-07-03 |
Terry Vance
BRD | Director/Board Member | 67 | 01-06-11 |
Yujiro Hata
BRD | Director/Board Member | 49 | 19-08-21 |
Director/Board Member | 64 | 13-09-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 21 155 983 | 19 865 549 ( 93,90 %) | 0 | 93,90 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+31,46% | 262 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |
- Beurs
- Aandelen
- Koers ENTA
- Onderneming Enanta Pharmaceuticals, Inc.